RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellevue, WA · Tacoma, WA · Vancouver, WA · +57 more sites
Crohn's Disease clinical trials in Tacoma, WA
11 recruiting crohn's disease studies with a site in Tacoma, WA.
RecruitingPhase 3NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Tacoma, WA · +21 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Bellevue, WA · Seattle, WA · +84 more sites
RecruitingPhase 3NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Sponsor: Takeda
Tacoma, WA · +12 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
Tacoma, WA · +34 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Tacoma, WA · +11 more sites
RecruitingPhase 2NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor: AbbVie
Seattle, WA · Tacoma, WA · +62 more sites
RecruitingPhase 2 / Phase 3NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Tacoma, WA · +60 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Tacoma, WA · +40 more sites
RecruitingPhase 3NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Sponsor: Takeda
Tacoma, WA · +13 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Bellevue, WA · Silverdale, WA · Tacoma, WA · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.